Kalpesh Vaghasiya (researcher)

author (P50)

Q93093907	Alginate Microspheres Elicit Innate M1-Inflammatory Response in Macrophages Leading to Bacillary Killing
Q99566412	Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy
Q51743270	HPLC-MS-MS Method Development and Validation of Antileishmanial Agent, S010-0269, in Hamster Serum.
Q92337851	Inhalation delivery of host defence peptides (HDP) using nano-formulation strategies: A pragmatic approach for therapy of pulmonary ailments
Q38634529	Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions
Q90985133	Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis
Q57174999	Nano-encapsulated HHC10 host defense peptide (HDP) reduces the growth of Escherichia coli via multimodal mechanisms
Q38255685	Novel pre-clinical methodologies for pharmacokinetic drug-drug interaction studies: spotlight on "humanized" animal models.
Q38802864	Preclinical pharmacokinetics and ADME characterization of a novel anticancer chalcone, cardamonin
Q47309646	Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells

P69	educated at	National Institute of Pharmaceutical Education and Research, S.A.S. Nagar	Q3631392
		Central Drug Research Institute	Q3633045
		Institute of Nano Science and Technology	Q18351683
		Panjab University Institute of Pharmaceutical Sciences	Q101003390
P108	employer	Panjab University Institute of Pharmaceutical Sciences	Q101003390
P106	occupation	researcher	Q1650915
P21	sex or gender	male	Q6581097

Kalpesh Vaghasiya